Answers are grounded in this paper and cite their sources.
Erythrodermic psoriasis (EP) is a potentially life-threatening disease, and there is currently no consensus regarding its optimal treatment. Biological drugs approved for Psoriasis Vulgaris treatment have been used as alternatives to traditional medications.
No takes yet. Share an insight, caveat, or question.
Falco et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: